MR Perfusion Imaging in Acute Ischemic Stroke

Neuroimaging Clinics of North America

Volumn 21, Issue 2, 2011, Pages 259-283

  Copen, William A ^a,b   Schaefer, Pamela W ^a,c   Wu, Ona ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain ischemia; Cerebrovascular circulation; Magnetic resonance imaging; Stroke

Indexed keywords

DESMOTEPLASE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

AUTOREGULATION; BLOOD CLOT LYSIS; BLOOD PRESSURE MONITORING; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN CIRCULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DRUG DOSE ESCALATION; FIBRINOLYTIC THERAPY; HEMODYNAMICS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; OXYGEN CONSUMPTION; OXYGEN EXTRACTION FRACTION; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; POSITRON; PRIORITY JOURNAL; RECANALIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; STROKE;

EID: 79957844243     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.02.007     Document Type: Review

References (157)

1. Rosen B.R., Belliveau J.W., Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989, 5:263-281.
2. Powers W.J. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991, 29:231-240.
3. Grubb R.L., Phelps M.E., Ter-Pogossian M.M. Regional cerebral blood volume in humans. X-ray fluorescence studies. Arch Neurol 1973, 28:38-44.
4. Grubb R.L., Phelps M.E., Raichle M.E., et al. The effects of arterial blood pressure on the regional cerebral blood volume by x-ray fluorescence. Stroke 1973, 4:390-399.
5. Stewart G.N. Researches on the circulation time in organs and on the influences which affect it, parts I-III. J Physiol (London) 1894, 15:1-89.
6. Kety S.S., King B.D., Horvath S.M., et al. The effects of an acute reduction in blood pressure by means of differential spinal sympathetic block on the cerebral circulation of hypertensive patients. J Clin Invest 1950, 29:402-407.
7. Hossmann K.A. Cerebral ischemia: models, methods and outcomes. Neuropharmacology 2008, 55:257-270.
8. Parsons M.W., Yang Q., Barber P.A., et al. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001, 32:1581-1587.
9. Jones T.H., Morawetz R.B., Crowell R.M., et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981, 54:773-782.
10. Astrup J., Siesjo B., Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981, 12:723-725.
11. Siesjö B.K. Pathophysiology and treatment of focal cerebral ischemia. Part I: pathophysiology. J Neurosurg 1992, 77:169-184.
12. Cordes M., Henkes H., Roll D., et al. Subacute and chronic cerebral infarctions: SPECT and gadolinium-DTPA enhanced MR imaging. J Comput Assist Tomogr 1989, 13:567-571.
13. Sette G., Baron J.C., Mazoyer B., et al. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography. Brain 1989, 112:931-951.
14. Weiller C., Ringelstein E.B., Reiche W., et al. Clinical and hemodynamic aspects of low-flow infarcts. Stroke 1991, 22:1117-1123.
15. Zaharchuk G., Mandeville J.B., Bogdanov A.A., et al. Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Stroke 1999, 30:2197-2204. [discussion: 2204-5].
16. Rubin G., Firlik A.D., Levy E.I., et al. Xenon-enhanced computed tomography cerebral blood flow measurements in acute cerebral ischemia: review of 56 cases. J Stroke Cerebrovas Dis 1999, 8:404-411.
17. Hakim A.M., Pokrupa R.P., Villanueva J., et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts. Ann Neurol 1987, 21:279-289.
18. Jorgensen H.S., Sperling B., Nakayama H., et al. Spontaneous reperfusion of cerebral infarcts in patients with acute stroke. Incidence, time course, and clinical outcome in the copenhagen stroke study. Arch Neurol 1994, 51:865-873.
19. Bowler J.V., Wade J.P., Jones B.E., et al. Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT. J Neurol Neurosurg Psychiatry 1998, 64:90-97.
20. Marchal G., Young A.R., Baron J.C. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab 1999, 19:467-482.
21. Marchal G., Furlan M., Beaudouin V., et al. Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome?. Brain 1996, 119:409-419.
22. Kidwell C.S., Saver J.L., Mattiello J., et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology 2001, 57:2015-2021.
23. Lassen N.A. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 1966, 2:1113-1115.
24. Williams D.S., Detre J.A., Leigh J.S., et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992, 89:212-216.
25. Rosen B.R., Belliveau J.W., Vevea J.M., et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990, 14:249-265.
26. Leenders K.L., Perani D., Lammertsma A.A., et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990, 113:27-47.
27. Wintermark M., Albers G.W., Alexandrov A.V., et al. Acute stroke imaging research roadmap. Stroke 2008, 39:1621-1628.
28. Boxerman J.L., Hamberg L.M., Rosen B.R., et al. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995, 34:555-566.
29. Donahue K.M., Krouwer H.G., Rand S.D., et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000, 43:845-853.
30. Kane I., Carpenter T., Chappell F., et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007, 38:3158-3164.
31. Beaulieu C., de Crespigny A., Tong D.C., et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999, 46:568-578.
32. Marks M.P., Tong D.C., Beaulieu C., et al. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999, 52:1792-1798.
33. Neumann-Haefelin T., Wittsack H.J., Wenserski F., et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999, 30:1591-1597.
34. Perkins C.J., Kahya E., Roque C.T., et al. Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms. Stroke 2001, 32:2774-2781.
35. Grandin C.B., Duprez T.P., Smith A.M., et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002, 223:361-370.
36. Wittsack H.J., Ritzl A., Fink G.R., et al. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 2002, 222:397-403.
37. Derex L., Nighoghossian N., Hermier M., et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci 2004, 225:3-9.
38. Yamada K., Wu O., Gonzalez R.G., et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 2002, 33:87-94.
39. Ribo M., Molina C.A., Rovira A., et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005, 36:602-606.
40. Cenic A., Nabavi D.G., Craen R.A., et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999, 20:63-73.
41. Nabavi D.G., Cenic A., Dool J., et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr 1999, 23:506-515.
42. Wintermark M., Thiran J.P., Maeder P., et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001, 22:905-914.
43. Gillard J.H., Antoun N.M., Burnet N.G., et al. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 2001, 74:552-555.
44. Furukawa M., Kashiwagi S., Matsunaga N., et al. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr 2002, 26:272-278.
45. Rempp K.A., Brix G., Wenz F., et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994, 193:637-641.
46. Østergaard L., Smith D.F., Vestergaard-Poulsen P., et al. Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab 1998, 18:425-432.
47. Hagen T., Bartylla K., Piepgras U. Correlation of regional cerebral blood flow measured by stable xenon CT and perfusion MRI. J Comput Assist Tomogr 1999, 23:257-264.
48. Sakoh M., Rohl L., Gyldensted C., et al. Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: comparison with [(15)O]H(2)O positron emission tomography. Stroke 2000, 31:1958-1964.
49. Smith A.M., Grandin C.B., Duprez T., et al. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging 2000, 12:400-410.
50. Lin W., Celik A., Derdeyn C., et al. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging 2001, 14:659-667.
51. Endo H., Inoue T., Ogasawara K., et al. Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography. Stroke 2006, 37:388-392.
52. Sorensen A.G., Buonanno F.S., Gonzalez R.G., et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996, 199:391-401.
53. Rordorf G., Koroshetz W.J., Copen W.A., et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998, 29:939-943.
54. Ueda T., Yuh W.T., Maley J.E., et al. Outcome of acute ischemic lesions evaluated by diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 1999, 20:983-989.
55. Sorensen A.G., Copen W.A., Østergaard L., et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999, 210:519-527.
56. Karonen J.O., Liu Y., Vanninen R.L., et al. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology 2000, 217:886-894.
57. Schaefer P.W., Hunter G.J., He J., et al. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 2002, 23:1785-1794.
58. Wintermark M. Brain perfusion-CT in acute stroke patients. Eur Radiol 2005, 15(Suppl 4):D28-D31.
59. Nagar V.A., McKinney A.M., Karagulle A.T., et al. Reperfusion phenomenon masking acute and subacute infarcts at dynamic perfusion CT: confirmation by fusion of CT and diffusion-weighted MR images. AJR Am J Roentgenol 2009, 193:1629-1638.
60. Benner T., Heiland S., Erb G., et al. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: Influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 1997, 15:307-317.
61. Lin W., Celik A., Paczynski R.P. Regional cerebral blood volume: a comparison of the dynamic imaging and the steady state methods. J Magn Reson Imaging 1999, 9:44-52.
62. deIpolyi AR, Wu O, Schaefer PW, et al. Cerebral blood volume measurements in acute ischemic stroke are technique-dependent and cannot substitute for DWI. American Society for Neuroradiology 48th Annual Meeting. Boston (MA), May 15-20, 2010.
63. Kwong K.K., Reese T.G., Nelissen K., et al. Early time points perfusion imaging. Neuroimage 2011, 54:1070-1082.
64. King R.B., Deussen A., Raymond G.M., et al. A vascular transport operator. Am J Physiol 1993, 265:H2196-H2208.
65. van Osch M.J., Vonken E.J., Wu O., et al. Model of the human vasculature for studying the influence of contrast injection speed on cerebral perfusion MRI. Magn Reson Med 2003, 50:614-622.
66. Rausch M., Scheffler K., Rudin M., et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn Reson Imaging 2000, 18:1235-1243.
67. Carroll T.J., Rowley H.A., Haughton V.M. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003, 227:593-600.
68. Mouridsen K., Christensen S., Gyldensted L., et al. Automatic selection of arterial input function using cluster analysis. Magn Reson Med 2006, 55:524-531.
69. Østergaard L., Weisskoff R.M., Chesler D.A., et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996, 36:715-725.
70. Østergaard L., Sorensen A.G., Kwong K.K., et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996, 36:726-736.
71. Kudo K., Sasaki M., Yamada K., et al. Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology 2010, 254:200-209.
72. Calamante F., Gadian D.G., Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000, 44:466-473.
73. Calamante F., Gadian D.G., Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002, 33:1146-1151.
74. Wu O., Østergaard L., Koroshetz W.J., et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003, 50:856-864.
75. Lythgoe D.J., Ostergaard L., William S.C., et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2000, 18:1-11.
76. Calamante F., Morup M., Hansen L.K. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med 2004, 52:789-797.
77. Lorenz C., Benner T., Lopez C.J., et al. Effect of using local arterial input functions on cerebral blood flow estimation. J Magn Reson Imaging 2006, 24:57-65.
78. Lorenz C., Benner T., Chen P.J., et al. Automated perfusion-weighted MRI using localized arterial input functions. J Magn Reson Imaging 2006, 24:1133-1139.
79. Christensen S., Mouridsen K., Wu O., et al. Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke 2009, 40:2055-2061.
80. Lee J.J., Bretthorst G.L., Derdeyn C.P., et al. Dynamic susceptibility contrast MRI with localized arterial input functions. Magn Reson Med 2010, 63:1305-1314.
81. Duhamel G., Schlaug G., Alsop D.C. Measurement of arterial input functions for dynamic susceptibility contrast magnetic resonance imaging using echoplanar images: comparison of physical simulations with in vivo results. Magn Reson Med 2006, 55:514-523.
82. Bleeker E.J., van Buchem M.A., van Osch M.J. Optimal location for arterial input function measurements near the middle cerebral artery in first-pass perfusion MRI. J Cereb Blood Flow Metab 2009, 29:840-852.
83. Rose S.E., Janke A.L., Griffin M., et al. Improving the prediction of final infarct size in acute stroke with bolus delay-corrected perfusion MRI measures. J Magn Reson Imaging 2004, 20:941-947.
84. Rose S.E., Janke A.L., Griffin M., et al. Improved prediction of final infarct volume using bolus delay-corrected perfusion-weighted MRI: implications for the ischemic penumbra. Stroke 2004, 35:2466-2471.
85. Wu O., Østergaard L., Weisskoff R.M., et al. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003, 50:164-174.
86. Baird A.E., Benfield A., Schlaug G., et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997, 41:581-589.
87. Grandin C.B., Duprez T.P., Smith A.M., et al. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke 2001, 32:1147-1153.
88. Fink J.N., Kumar S., Horkan C., et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002, 33:988-993.
89. Coutts S.B., Simon J.E., Tomanek A.I., et al. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke 2003, 34:1681-1683.
90. Ay H., Koroshetz W.J., Vangel M., et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005, 36:2632-2636.
91. Yoo A.J., Barak E.R., Copen W.A., et al. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with national institutes of health stroke scale score improves the prediction of acute stroke outcome. Stroke 2010, 41:1728-1735.
92. Rivers C.S., Wardlaw J.M., Armitage P.A., et al. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?. Stroke 2006, 37:98-104.
93. Shih L.C., Saver J.L., Alger J.R., et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003, 34:1425-1430.
94. Olivot J.M., Mlynash M., Thijs V.N., et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009, 40:469-475.
95. Bang O.Y., Lee K.H., Kim S.J., et al. Benign oligemia despite a malignant MRI profile in acute ischemic stroke. J Clin Neurol 2010, 6:41-45.
96. Kidwell C.S., Saver J.L., Mattiello J., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
97. Kakuda W., Lansberg M.G., Thijs V.N., et al. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008, 28:887-891.
98. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60:508-517.
99. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7:209-309.
100. Liebeskind D.S. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am 2005, 15:553-573. x.
101. Christensen S., Calamante F., Hjort N., et al. Inferring origin of vascular supply from tracer arrival timing patterns using bolus tracking MRI. J Magn Reson Imaging 2008, 27:1371-1381.
102. Lövblad K.O., Laubach H.J., Baird A.E., et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998, 19:1061-1066.
103. Singer M.B., Chong J., Lu D., et al. Diffusion-weighted MRI in acute subcortical infarction. Stroke 1998, 29:133-136.
104. van Everdingen K.J., van der Grond J., Kappelle L.J., et al. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998, 29:1783-1790.
105. Gonzalez R.G., Schaefer P.W., Buonanno F.S., et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999, 210:155-162.
106. Urbach H., Flacke S., Keller E., et al. Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology 2000, 42:722-727.
107. Fiebach J.B., Schellinger P.D., Jansen O., et al. CT and diffusion-weighted MR imaging in randomized order: diffusion- weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002, 33:2206-2210.
108. Mullins M.E., Schaefer P.W., Sorensen A.G., et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002, 224:353-360.
109. Hand P.J., Kwan J., Lindley R.I., et al. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke 2006, 37:769-775.
110. Johnston S.C., Gress D.R., Browner W.S., et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284:2901-2906.
111. Furie K.L., Kasner S.E., Adams R.J., et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42(1):227-276.
112. Coutts S.B., Sylaja P.N., Choi Y.B., et al. The aspire approach for TIA risk stratification. Can J Neurol Sci 2011, 38:78-81.
113. Ovbiagele B., Kidwell C.S., Saver J.L. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 2003, 34:919-924.
114. Restrepo L., Jacobs M.A., Barker P.B., et al. Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol 2004, 25:1645-1652.
115. Krol A.L., Coutts S.B., Simon J.E., et al. Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 2005, 36:2487-2489.
116. Mlynash M., Olivot J.M., Tong D.C., et al. Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Neurology 2009, 72:1127-1133.
117. NINDS rt-PA Study Group Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581-1587.
118. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
119. Hacke W., Kaste M., Fieschi C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators. Lancet 1998, 352:1245-1251.
120. Clark W.M., Wissman S., Albers G.W., et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The Atlantis Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999, 282:2019-2026.
121. Wahlgren N., Ahmed N., Davalos A., SITS-MOST investigators, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 2007, 369:275-282.
122. Bluhmki E., Chamorro A., Davalos A., et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009, 8:1095-1102.
123. Boode B., Welzen V., Franke C., et al. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis 2007, 23:294-298.
124. Smith M.A., Doliszny K.M., Shahar E., et al. Delayed hospital arrival for acute stroke: the Minnesota stroke survey. Ann Intern Med 1998, 129:190-196.
125. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000, 283:1151-1158.
126. Barber P.A., Zhang J., Demchuk A.M., et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001, 56:1015-1020.
127. O'Connor R.E., McGraw P., Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 1999, 33:9-14.
128. Tong D.C., Yenari M.A., Albers G.W., et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998, 50:864-870.
129. Karonen J.O., Vanninen R.L., Liu Y., et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. Stroke 1999, 30:1583-1590.
130. Parsons M.W., Barber P.A., Chalk J., et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002, 51:28-37.
131. Grant P.E., He J., Halpern E.F., et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001, 221:43-50.
132. Barber P.A., Darby D.G., Desmond P.M., et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998, 51:418-426.
133. Schlaug G., Benfield A., Baird A.E., et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999, 53:1528-1537.
134. Hacke W., Albers G., Al-Rawi Y., et al. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73.
135. Furlan A.J., Eyding D., Albers G.W., et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227-1231.
136. Nagakane Y., Christensen S., Brekenfeld C., et al. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration. Stroke 2011, 42:59-64.
137. Hacke W., Furlan A.J., Al-Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009, 8:141-150.
138. Rose S.E., Chalk J.B., Griffin M.P., et al. MRI based diffusion and perfusion predictive model to estimate stroke evolution. Magn Reson Imaging 2001, 19:1043-1053.
139. Wu O., Koroshetz W.J., Østergaard L., et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 2001, 32:933-942.
140. Han J.H., Wong K.S. Is counterpulsation a potential therapy for ischemic stroke?. Cerebrovasc Dis 2008, 26:97-105.
141. Uflacker R., Schonholz C., Papamitisakis N. Interim report of the SENTIS trial: Cerebral perfusion augmentation via partial aortic occlusion in acute ischemic stroke. J Cardiovasc Surg (Torino) 2008, 49:715-721.
142. Singhal A.B., Benner T., Roccatagliata L., et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36:797-802.
143. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International stroke trial collaborative group. Lancet 1997, 349:1569-1581. International Stroke Trial Collaborative Group.
144. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997, 349:1641-1649. CAST (Chinese Acute Stroke Trial) Collaborative Group.
145. Barer D.H., Cruickshank J.M., Ebrahim S.B., et al. Low dose beta blockade in acute stroke (" BEST" trial): an evaluation. Br Med J (Clin Res Ed) 1988, 296:737-741.
146. Ahmed N., Nasman P., Wahlgren N.G. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000, 31:1250-1255.
147. Horn J., Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001, 32:570-576.
148. Ahmed N., Wahlgren N.G. Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc Dis 2003, 15:235-243.
149. Rordorf G., Cramer S.C., Efird J.T., et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997, 28:2133-2138.
150. Hillis A.E., Ulatowski J.A., Barker P.B., et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003, 16:236-246.
151. Mistri A.K., Robinson T.G., Potter J.F. Pressor therapy in acute ischemic stroke: systematic review. Stroke 2006, 37:1565-1571.
152. Krieger D.W., Demchuk A.M., Kasner S.E., et al. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999, 30:287-292.
153. Bowes M.P., Zivin J.A., Thomas G.R., et al. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol 1996, 141:40-46.
154. Fagan S.C., Bowes M.P., Lyden P.D., et al. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol. Exp Neurol 1998, 150:153-158.
155. Vemmos K.N., Spengos K., Tsivgoulis G., et al. Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens 2004, 18:253-259.
156. Okumura K., Ohya Y., Maehara A., et al. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005, 23:1217-1223.
157. Ahmed N., Wahlgren N., Brainin M., et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR). Stroke 2009, 40:2442-2449.